Last filing: Sep 11, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gilead Sciences (GILD) | Chief Medical Officer | Jan 3, 2025 | Sep 11, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 10, 2026, Gilead Sciences: 533 shares vested; 263 shares withheld by the company for taxes. 1 filing: 1
- Jun 10, 2026, Gilead Sciences: 533 shares vested; 263 shares withheld by the company for taxes. 1 filing: 1
- Mar 10, 2026, Gilead Sciences: 2,133 shares vested; 1,063 shares withheld by the company for taxes. 1 filing: 1
- Feb 27, 2026, Gilead Sciences: 8,530 shares awarded. 1 filing: 1
- Jan 2, 2026, Gilead Sciences: 16,326 shares vested; 6,944 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.